LEADER 04569nam 22005895 450 001 9910380738903321 005 20200702075908.0 010 $a981-15-1424-0 024 7 $a10.1007/978-981-15-1424-1 035 $a(CKB)4100000010349040 035 $a(MiAaPQ)EBC6038359 035 $a(DE-He213)978-981-15-1424-1 035 $a(EXLCZ)994100000010349040 100 $a20200203d2020 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aIntegrity, Transparency and Corruption in Healthcare & Research on Health, Volume I /$fedited by K?ymet Tunca Çal?yurt 205 $a1st ed. 2020. 210 1$aSingapore :$cSpringer Singapore :$cImprint: Springer,$d2020. 215 $a1 online resource (266 pages) 225 1 $aAccounting, Finance, Sustainability, Governance & Fraud: Theory and Application,$x2509-7873 300 $aIncludes index. 311 $a981-15-1423-2 327 $a1. Transparency and Conflicts in Science: History of Influence, Scandal, and Denial -- 2. The Health Impact Fund and the Problem of Corruption in the Global Pharmaceutical Sector -- 3. Outsourced Services in Private Healthcare Organizations and ISAE 3402 Assurance Engagement: A Research Focused on Turkey -- 4. Revisiting Accountability: Corruption in Healthcare in Developing Countries -- 5. Corruption of the Canadian drug regulatory system -- 6. Professional ethics, professionalization and regulation of Pharmaceutical Sales Representatives, Analyzing the Costa Rican Case -- 7. Exploring Accountability and Transparency within International Organizations: What Do We Know and What do we Need to Know? -- 8. Medical Ghost- and Guest-Writing as Corrupt Practices and How to Prevent Them -- 9. Fraudulent Misrepresentation and Fraudulent Concealment in Products Liability in Tort Law in Canada: The Special Relationship between Drug Companies and Consumers in the Context of the Fraudulent Misrepresentation and Fraudulent Concealment of Data -- 10. The Role of Procurement Department in Governmental Hospital -- 11. Communicating Integrity framework information on Malaysian private hospitals? websites. 330 $aThis book grapples with the numerous risks organizations face in order to succeed. These include economic risks, disaster risks, supply-chain risks, regulatory risks, and technology risks, all of which affect organizations in different ways and in varying degrees. Referencing Mahatma Gandhi?s seven unethical behaviors in the business world?wealth without work, pleasure without conscience, knowledge without character, commerce without morality, science without humanity, religion without sacrifice, and politics without principle?the authors analyze the healthcare sector. As competition in the health sector increases, there has also been a rise in unethical behavior. Corruption in the health sector results in severe consequences as it could affect the health of millions. This volume explores fraud schemes and cases, legislation to avoid cheating, lack of law, transparency, ethical issues, corporate governance and transparency in the health and pharmaceutical sector bringing together the perspectives of practitioners, professionals, as well as academic authors. 410 0$aAccounting, Finance, Sustainability, Governance & Fraud: Theory and Application,$x2509-7873 606 $aResearch?Moral and ethical aspects 606 $aHealth care management 606 $aHealth services administration 606 $aCorporate governance 606 $aResearch Ethics$3https://scigraph.springernature.com/ontologies/product-market-codes/E14040 606 $aHealth Care Management$3https://scigraph.springernature.com/ontologies/product-market-codes/527030 606 $aCorporate Governance$3https://scigraph.springernature.com/ontologies/product-market-codes/511020 615 0$aResearch?Moral and ethical aspects. 615 0$aHealth care management. 615 0$aHealth services administration. 615 0$aCorporate governance. 615 14$aResearch Ethics. 615 24$aHealth Care Management. 615 24$aCorporate Governance. 676 $a362.1068 702 $aÇal?yurt$b K?ymet Tunca$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910380738903321 996 $aIntegrity, Transparency and Corruption in Healthcare & Research on Health, Volume I$91921365 997 $aUNINA